Alex M Azar II insider trades: Guardant Health (GH) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Alex reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 14, 2026 | GH | ↓ Sell | 69 | $159.89 | $11K | Direct | Oct 15, 2026 (1d) |
| Sep 16, 2026 | GH | ↓ Sell | 826 | $175.00 | $145K | Direct | Sep 17, 2026 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other GH insiders
Open-market trades in the last 12 months
About Alex M Azar II's insider trades
Alex M Azar II is a director at Guardant Health (GH). Since Sep 16, 2026, Alex has reported no open-market purchases and 2 sales worth $156K on SEC Form 4. In the last 12 months: 2 sales ($156K).
Their filings also include grants and awards (10 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.